A once-daily combination treatment for those with uncontrolled Type 2 diabetes amplifies the treatment’s effects – lowering both weight and the number of hypoglycemic events, and improving quality of life and glucose control ¬– and makes participants more likely to adhere to their medications.

Breastfeeding secures delivery of sugar and fat for milk production by changing the insulin sensitivity of organs that supply or demand these nutrients, a new study led by UT Southwestern scientists suggests.

UT Southwestern’s Dr. Philipp Scherer has become the first scientist to win what could be called the “Triple Crown” of diabetes research recognition – adding the top Asian award to the American and European ones he claimed earlier.

Brain cancer patients in the coming years may not need to go under the knife to help doctors determine the best treatment for their tumors.

Artificial intelligence can help cancer patients start their radiation therapy sooner – and thereby decrease the odds of the cancer spreading – by instantly translating complex clinical data into an optimal plan of attack.

COVID-19 patients who receive a palliative care consultation are 5.6 times more likely to receive comfort care at the end of life and are just as likely to receive CPR if needed as those who did not receive a consultation, according to a UT Southwestern study.

Four generations of women, who all have the same hereditary condition – familial hypercholesterolemia – form a story interwoven with the discovery of new treatments that have benefited millions of people.

A UT Southwestern study suggests why urinary tract infections have such a high recurrence rate in postmenopausal women.

Katie Sturm had nearly gotten over the shock of learning she was pregnant with quadruplets when in February she suffered a seizure at work. She was diagnosed with a brain tumor, which was removed at UT Southwestern in March.

Researchers have discovered that a molecule – estrogen-related receptor gamma, or ESRRG – becomes hyperactive and promotes tumor cell survival in retinoblastoma.